| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | MCH2; Cysteinyl Aspartate Specific Proteinases 6; Caspase 6,Apoptosis-Related Cysteine Peptidase; Apoptotic protease Mch-2 |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, plasma, tissue homogenates, cell lysates and other biological fluids. |
| Sensitivity | |
| Target | |
| UniProt # |
Scientific background
CASP6 (Caspase 6) is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).
Protein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.
Quantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.
Why it matters
- Quantify CASP6 (Caspase 6) to compare biological changes across conditions, doses, or time points.
- Generate concentration data from a standard curve to support biomarker and mechanistic studies.
How the ELISA works
Designed for Rat samples, this kit uses a The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Rat CASP6. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Rat CASP6. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Rat CASP6, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Rat CASP6 in the samples is then determined by comparing the OD of the samples to the standard curve.. After binding and washing, signal is converted to concentration using a standard curve.
Sample types: Serum, plasma, tissue homogenates, cell lysates and other biological fluids.
- Detection range: 0.16-10 ng/mL
- Sensitivity/LoD: 0.065 ng/mL
- Assay time: 3.5h
Can?t Find What You?re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
CARDIOVASCULAR DRUGS AND THERAPY
Butyrate-Mediated Modulation of Paraoxonase-1 Alleviates Cardiorenometabolic Abnormalities in a Rat Model of Polycystic Ovarian Syndrome
Nutrire
Butyrate alleviates adipose mitochondrial dysfunction and inflammation in experimental model of polycystic ovarian syndrome by modulating SIRT1-dependent mechanism
The Journal of Physiological Sciences
Acetate ameliorates ovarian mitochondrial dysfunction in letrozole-induced polycystic ovarian syndrome rat model by improving mitofusin-2
STEROIDS
Acetate abates adipose-ovarian endocrinometabolic disturbance in experimentally induced polycystic ovarian syndrome
BMC Research Notes
Acetate attenuates hypothalamic pyroptosis in experimentally induced polycystic ovarian syndrome
Comparative Clinical Pathology
Modulation of PON-1 by acetate reverses hepatic dysmetabolism in experimentally induced PCOS
Comparative Clinical Pathology
Hepatic dysmetabolism in polycystic ovarian syndrome: impact of paraoxonase-1 modulation by butyrate
Comparative Clinical Pathology
Butyrate ameliorates ovarian failure in experimental PCOS rat model by suppression of HDAC2